Leading youth sports management software provider, EventConnect announced a new long-term partnership with Athletx Sports Group, one of the most prominent organizers of youth baseball leagues and tournaments in the U.S. Recent and rapid growth had propelled Athletx to being ranked #1,214 on the Inc. 5000 list, which recognizes the fastest-growing private companies nationally, and #3 in the Business First Fast 50, which recognizes the fastest-growing private companies in the Louisville area.
LONDON, Ontario, April 27, 2023 (Newswire.com)
-
Today, EventConnect, the leading youth sports management software provider, announced a new long-term partnership with Athletx Sports Group. As the exclusive tournament accommodations provider, Athletx will start by integrating EventConnect's sports technology alongside the Athletx custom-built platform to help streamline operations while maximizing hotel and vacation rental accommodation revenues.
"Based on our continued growth as a company, we are excited to partner with EventConnect as they will allow a more user-friendly experience for our families participating in our tournaments. This partnership benefits our families and hotel partners by providing a seamless experience for both parties. With our continual growth in the sports tournament market, we look forward to a growing partnership with EventConnect," said Justin Siegel, Executive Director of Housing at Athletx.
"Athletx Sports Group is focused on providing first-class experiences for our players, families and fans in the youth baseball and softball market. Partnering with EventConnect is exciting for our company as their services will continue providing excellent customer experiences. Streamlining our processes from start to finish is of the utmost importance. EventConnect aligns with Athletx's vision, which makes this partnership so important. We are thrilled to be partners with EventConnect and look forward to working with their brilliantly executed technology platform and top-notch team." -Jim Haddaway, Co-Founder and CEO of Athletx
"We are more than thrilled about this important new partnership with Athletx, and it is yet another example of our connection and dedication to the sport of Baseball," said Eric Vardon, President of EventConnect. "Athletx is such a powerful and meaningful brand, and to say we are partners is a substantial milestone for our growing tech company. Since 2013 we have continued to invest in our product and team to realize our vision to continually advance the ease and efficiency of sports tournament management with innovative technology matched with unparalleled service and support - today is a huge step toward that vision. We can't wait to hit the ground running with the Athletx team," Vardon added.
About Athletx Sports Group
Athletx brings together multiple nationally-recognized brands under one family, including Pastime Tournaments, Youth Baseball & Softball Nationals, Youth World Series, Game Day USA, Baseball Youth/Softball Youth, Mid-America Baseball, VERSUS, New Year's BaseballFest, TravelBall Select and Drive & Company. Recent and rapid growth has propelled Athletx to being ranked #1,214 on the Inc. 5000 list, which recognizes the fastest-growing private companies nationally, and #3 in the Business First Fast 50, which recognizes the fastest-growing private companies in the Louisville area. Athletx Sports Group and its brands collectively represent nearly 600 team-based and individual-player events across the nation, featuring over 15,000 teams, 194,000 players, 38,000 coaches and 371,000 spectators. These events have featured athletes and teams from all 50 U.S. states and internationally, including Mexico, Puerto Rico, Dominican Republic, Venezuela, Bahamas, Germany, Japan, Kuwait, Australia, Canada and the United Kingdom. In addition to producing first-class events, Athletx boasts a strong media presence with over 720,000 social media followers across its brands' various Facebook, Twitter, Instagram and TikTok platforms. Athletx maintains offices in Louisville, KY (corporate headquarters), Chicago, IL (Naperville) and Indianapolis, IN (Carmel). For more information, visit www.athletx.com.
About EventConnect
EventConnect is the only event management software in the sports tourism industry that connects thousands of rights holders, tournament directors and accommodations on one platform—working with more than 4,000 events and 20,000 hotels in over 800 cities across North America. EventConnect helps sports tournament organizers reduce time spent on administrative tasks and increase capacity for delivering memorable experiences to all participants. The end-to-end platform is customized for each partner's needs and is seamless for organizers and participants, creating efficiency while increasing value. EventConnect customers can increase room night reservations by up to 30% while saving up to 24% of hotel costs for teams and creating a 99% rate of booking satisfaction and positive experiences. Learn more at http://eventconnectsports.com.
Contact Information:
Eric Vardon
President [email protected]
5198515386
Christine Herring
VP , Strategy & Business Development [email protected]
502-436-7684
RIDGEFIELD, Conn., April 27, 2023 (Newswire.com)
-
BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. The first research project of the new lab will focus on fibrotic disease processes, a key focus area of Boehringer Ingelheim. It will aim for a better understanding of wound healing and fibrosis in diseases of high unmet need, such as non-alcoholic steatohepatitis (NASH), scleroderma, progressive fibrosing interstitial lung diseases (PF-ILDs), and Crohn's disease, to pave the way for developing treatments that significantly improve patient outcomes.
Using its global crowdsourcing process, the BioMed X Institute will recruit a team of outstanding early-career life scientists to form a first-of-its-kind research group that will be hosted at Boehringer Ingelheim's US site in Ridgefield, CT. The goal of this new collaboration is to bring BioMed X's successful innovation model to Boehringer Ingelheim's main US research and development campus and serve as a nucleus for a vibrant external innovation ecosystem. This collaborative effort will aim to further fertilize the company's research and development initiatives in an effort to transform the lives of patients with high unmet medical needs.
Dr. Christian Tidona, Founder and Managing Director of BioMed X, explains: "The principle behind BioMed X has always been to combine the best of both worlds - academia and industry. We started by creating an independent research institute located on a traditional university campus in Heidelberg, Germany. Now, backed by 10 years of experience, we were able to translate the BioMed X concept into something that can be implemented on a research and development campus of a pharmaceutical company. We are grateful to Boehringer Ingelheim for embracing this new concept."
The XSeed Labs will be managed by the newly founded BioMed X Institute in New Haven, CT, which is also home to the world-renowned Yale University. "We are excited to establish this new model here in the US, which will allow us to promote scientific exchange between all major players in the field of biomedical research," says Mark Johnston, CEO of BioMed X USA.
Within the XSeed Labs framework, the teams will focus on chronic fibroinflammatory disease hallmarks such as aberrant tissue repair, pathological matrix production, macrophage and fibroblast activation, as well as metabolic reprogramming. To understand the molecular mechanisms underlying fibrosis as compared to normal wound healing, more complex and physiologically relevant disease models are needed. The new research group at XSeed Labs will focus on developing complex ex vivo tissue culture models to study this process to develop innovative therapies that significantly reduce the progression of fibrosis.
Life sciences researchers who are interested in becoming part of this new BioMed X team on the Boehringer Ingelheim Ridgefield campus are invited to respond to this international call for applications by submitting a project proposal via the BioMed X Career Space (https://career.bio.mx/call/2023-RDG-C01) before June 18, 2023.
About BioMed X and XSeed Labs
BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany, with a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds - academia and industry - and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
BioMed X started working with Boehringer Ingelheim in 2015 with a series of joint research projects hosted by the BioMed X Institute in Heidelberg, Germany. The new collaboration model - called XSeed Labs - entails an open innovation incubator embedded in the Boehringer Ingelheim Ridgefield campus in Connecticut, USA. The topic of the first research project within this new framework is wound healing and fibrosis.
Wound Care Clinicians Can Now Manage All Wound Care Documentation, MolecuLight Images and Measurements via a Robust, Scalable Cloud Platform
NATIONAL HARBOR, Md., April 27, 2023 (Newswire.com)
-
Perceptive Solutions, Inc. announced today that the company has partnered with MolecuLight Corp., the leader in point-of-care fluorescence imaging that detects and locates elevated bacterial loads in wounds, to deliver a cloud-based wound management solution via its WoundZoom® platform that will be integrated with the MolecuLightDX™ point-of-care bacterial imaging device. The new partnership is being announced at the SAWC (Symposium for the Advancement of Wound Care) Spring 2023 conference, April 27 - 29, 2023, being held in National Harbor, MD. Both companies will be exhibiting side-by-side (Perceptive Solutions/WoundZoom at booth #631; MolecuLight at booth #627) and will be demonstrating their respective products, as well as discussing the integrated imaging - wound management solution.
With the integrated solution, wound care clinicians will now be able to benefit from having bacterial imaging and digital wound measurement as well as an industry-leading total cloud-based wound management system, including:
Comprehensive patient/wound documentation and tracking,
Wound department analytics and dashboarding, and
Cloud-based synchronization of multiple MolecuLightDX devices.
For customers that are interested in this novel cloud solution, the integration of the MolecuLightDX device with WoundZoom will automate image and measurement uploading, synchronize data across multiple DX devices in a facility, and allow department administrators to focus on continuous improvement of patient care and wound care operations.
"We are thrilled to announce our integration of the MolecuLightDX with WoundZoom to provide an industry-leading solution for cloud-based wound management," says Anil Amlani, MolecuLight's CEO. "Our extensive body of clinical evidence reveals how MolecuLight informs clinical decision-making, enabling wound care clinicians to achieve improved outcomes. These published results show faster healing rates, reduced costs including reduced use of antibiotics and antimicrobial dressings, and improved patient engagement and involvement in their wound healing efforts. With the integration to WoundZoom, clinicians can further improve efficiencies from comprehensive dashboarding and department-wide analytics, real-time connectivity and synchronization of their multiple MolecuLight devices to the cloud. The potential for improved documentation, operational efficiencies and for tracking patient progress is significant".
"WoundZoom is providing a new level of efficiency, transparency and centralized decision-making for the wound care clinicians and administrators across all sites of service in the US," says Mark Lacerte, CEO of Perceptive Solutions. "The ability to now have point-of-care diagnostic imaging provided by the MolecuLightDX device provides a more robust view of a patient's wounds and allows clinicians to make more informed decisions about wound hygiene and treatment planning. Added to our robust wound management platform, we can now facilitate more comprehensive documentation and reporting of department operational efficiencies, and ultimately, improved patient outcomes."
The MolecuLight i:X and DX are the only imaging devices for the real-time detection of elevated bacterial burden in wounds that are FDA-cleared, CE-Marked and approved by Health Canada. With clinical evidence including over 75 peer-reviewed publications involving 1,500 patients, the devices are used by leading wound care facilities globally.
MolecuLight Corp. is the US subsidiary of MolecuLight Inc., a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight's suite of commercial devices, which include the MolecuLight i:X® and DX™fluorescence imaging systems and their accessories, are point-of-care handheld imaging devices for the real-time detection and localization of bacterial load in wounds and digital wound measurement. MolecuLight procedures performed in the United States benefit from an available reimbursement pathway which includes two CPT® codes for physician work to perform "fluorescence imaging for bacterial presence, location, and load" and facility payment for Hospital Outpatient Department (HOPD) and Ambulatory Surgical Center (ASC) settings through an Ambulatory Payment Classification (APC) assignment. The company is also commercializing its unique fluorescence imaging platform technology for other global markets with relevant unmet needs in food safety, consumer cosmetics and other key industrial markets.
About Perceptive Solutions, Inc.
Perceptive Solutions, Inc. is a privately-owned Software as a Service (SAAS) company with focus on healthcare. Perceptive Solutions product portfolio includes point-of-care mobile applications WoundZoom Core®, WoundZoom Pro® and cloud-based WoundZoom Connect® clinical portal. Founded in 2012 as WoundZoom, Inc., the company was the first to market with a point-and-click wound measurement camera and assessment tool. Our vision is to modernize the practice of wound care with technology-enabled systems designed to increase clinical efficiencies, improve care quality and mitigate risk.
Contact Information:
Rob Sandler
Chief Marketing Officer, Moleculight, Inc. [email protected]
647-362-4684
Once upon a time being a nerd was looked at as a negative, with depictions of them being scrawny losers with glasses and high pitched voices who loved comic books and wouldn’t know how to throw a baseball unless Captain America taught them how. But something happened. Geek culture became mainstream culture and the people who brought it to us were the ones who once felt so alienated by their seemingly uncool passions. Enter Joss Whedon who used his childhood isolations to craft some of the biggest cult hit TV shows and penned many groundbreaking screenplays – everything from sci-fi to horror to action adventure to animation to Shakespeare and some of the biggest superhero flicks ever. But behind closed doors there seemed to be a different tale, a story of a man so consumed with ego that he made everyone else tremble in terror around him. It would seem that Joss Whedon was not the hero he thought he was, but the villain we weren’t expecting. How did a man so deified in nerd culture have a fall from grace on par with some of the comic book characters he wrote about? Its time we find out just WTF Happened to Joss Whedon!
NOTE: The episode of WTF Happened to this Celebrity is written by Brad Hamerly and Taylor Johnson. The video embedded above is narrated, produced and edited. by Taylor James Johnson.
But as always we must begin at the beginning and the beginning began on his birthday, June 23, 1964 in the Upper West Side of New York City as Joseph before changing his name to Joss later in life because it was Chinese for Luck. And he was lucky enough to land a staff writing gig on hit ABC series Roseanne where he wrote four episodes for the second season before switching over to the show Parenthood based off the hit film. However this was not the popular Parenthood that aired in 2010, but rather a failed sitcom starring a young Leonardo DiCaprio that only lasted a single season.
During this time, Whedon would write a spec script about a teenage girl named Buffy who hunts vampires called Buffy The Vampire Slayer. Unfortunately studio executives took the script Whedon wrote and slayed it, removing humor and darker elements of the plot. Ya know, the two elements that work in Buffy. The comedy and the horror. The result was a film that pulled in just $16.6 million at the box office with critics saying it was a giant let down, but no one was more let down than Joss Whedon who saw his first attempt at theatrical success go up in flames through no fault of his own. It would be something that would eat at him for a few years until he could eventually right that wrong. In the meantime, Whedon would make a name for himself as a ghost writer, essentially someone who takes a script and does uncredited rewrites. From 1994 until the year 2000, you would watch films such as The Getaway, Speed, The Quick and the Dead, Waterworld, Twister and X-Men without knowing some of what you were enjoying came from the mind of Joss Whedon.
In 1995, Whedon would land his first and to date only Academy Award nomination as one of the writers on the groundbreaking Pixar film Toy Story. The script had been in development for several years but just didn’t quite have the wow factor. So Pixar sought out Whedon to punch it up, which he did by adding the character of Rex and giving a more substantial role for Bo Peep as well as taking the Buzz Lightyear character from a dim-witted self aware character to an action figure that doesn’t know he is a toy which many say saved the film.
In 1997, 20th Century Fox would hire Whedon to write a new film in the Alien franchise. At the time, Sigourney Weaver was not expected to return for a fourth film, as her character had died at the end of Alien 3, so Whedon wrote a screenplay that took place on earth and featured a clone of the Aliens character Newt. However, executives soon pivoted to wanting to bring back Weaver for the film and told Whedon to come up with a new story that featured the resurrection of the Ripley character, so he did! And he kept the cloning idea he had originally intended for Newt and assigned it to Ripley and when Weaver read the script she was intrigued, saying the script brought back the spirit of the first two films and she immediately signed on.
With two interesting scripts produced into films he didn’t enjoy (the Alien script became the divisive Alien: Resurrection), Whedon was getting a bit dissuaded form the business, but then Dolly Parton’s Sandollar Studios called him and told him they loved the original script for Buffy that he submitted. They asked him to film a short pitch video for executives at Warner Brothers television. This prospect kind of intimidated Whedon as he had never directed anything before but he loved the idea of actually being able to get what he originally envisioned on film. Warner Brothers picked up the show Buffy The Vampire Slayer, giving it a relatively small budget as the WB network at the time was struggling, which just meant Whedon had to rely more on the story telling rather than the special effects, He did so by digging into his youth, when he felt like an outsider at school. During the course of the show Whedon would be nominated for several awards including an Emmy Award for Outstanding Writing for a Drama Series and a Bram Stoker Award for Best Screenplay for the episode “Hush”. Whedon would then successfully spin-off the series with Angel that ran for 5 seasons and was considered a darker more adult skewing show. The show was unceremoniously canceled after season 5 which caught Whedon off guard as he thought that after 100 episodes the show was finally coming into its own.
In theaters, Whedon would head back to where he had the most success: animation, by penning the script for the Fox Animation Studio film Titan A.E that sadly tanked at the box office with just $36.8 million off a reported near $100 million budget. He would follow that up by being one of the people to help develop the story for the Walt Disney Animated feature Atlantis: The Lost Empire. The film would do decent numbers, pulling in over $186 million worldwide, but with a large $120 million budget it was deemed a financial disappointment. Of course this didn’t affect Whedon much as he says the final version of the film had not a single shred of anything he contributed to it.
Back on TV, Whedon would solidify his geek god status by creating the space western Firefly which despite it garnering a very dedicated fan base, only ran for a single season with just 14 episodes produced. TV Guide would rank the show at number 5 on their list of 60 shows that were cancelled too soon. Whedon developed the show after reading the book The Killer Angels about the Battle of Gettysburg during the American Civil War and became fascinated by telling a story about people who had fought on the losing side of a war. Despite the cancellation, Whedon immediately started writing a film script for the series and contacted anyone he could about making it. Luckily Universal saw potential, mainly due to stellar DVD sales of the series. In 2005 Whedon would make his feature directorial debut with Serenity, which sadly showed that the vocal fan base was not the majority when the film failed to perform at the box office with releases in several international countries scrapped in favor of a direct to DVD release. But, there was some light at the end of that tunnel as SFX magazine named it the best science fiction film of all time while Empire magazine would rank it #383 on its list of the 500 greatest movies of all time list. After these perceived failures, Whedon took a bit of a break, taking on some guest directing gigs on shows such as The Office and Glee but would step back into the world of Sci-Fi television by creating another short lived but now cult classic show Dollhouse, which would only air for 2 seasons before being canceled.
After making the Creative Arts Emmy winning Dr. Horrible’s Sing-Along Blog in 2008, Whedon would make his way back to the big screen by co-writing the horror comedy Cabin in the Woods which was one of the best horror films of the last 15 years in my most humble of opinions, and my opinions are always humble! The pair is reported to have written the screenplay for this film in just three days. It really is that perfect Whedon style script where it infuses science fiction tropes with genuine laugh out loud comedy while also making fun of the very genre they are making.
But the biggest turn for Joss Whedon was waiting just around the corner. Marvel Studios had built up an increasingly successful arsenal of films, starting with 2008’s Iron Man which teased some sort of Avengers Initiative in its post credits scene. But who would direct such a massive endeavor that would bring together the biggest super heroes of the moment for an epic mash up? Enter Joss Whedon who grew up reading comic books and had earned his stripes writing for Marvel Comics over the years. Whedon was announced as the director in July 2010. After receiving the script written by Zak Penn, he told Kevin Feige that they had absolutely nothing and decided to do a page one rewrite. The Avengers would release on May 4, 2012 and break nearly every record at the time including highest grossing opening weekend ever with $207.4 million, which really does owe a lot to Whedon’s writing which you can feel in every joke. A lot of the Marvel films have stale humor, but Whedon’s Avengers script had several scenes with genuine bust out laughing moments like when Hulk just punches Thor or the entire post credits scene of the Avengers, broken and beaten from battle, just enjoying some Shwarma, which was an idea that Whedon had on a whim during post-production.
Whedon would then take on a few smaller passion projects in the wake of The Avengers massive success including the modern day retelling of William Shakespeare’s Much Ado About Nothing (2012). But soon, Whedon would jump back into the world of The Avengers for its sequel Avengers: Age of Ultron which was another monster hit, grabbing over $1.4 Billion worldwide. Whedon would then help launch the Marvel series Agents of Shield writing and directing the pilot episode. But it would seem his time with Marvel was soon wrapping up, so what would be next for Whedon? At the time, DC was putting together their own Super Hero mash up film titled Justice League. The film’s director was Zack Snyder and the film he was making was darker. This reportedly didn’t sit well with Warner Brothers execs who thought Snyder’s first two films were too dark and lacked that fun aspect the Marvel films had. Sadly, during production, Snyder suffered an unimaginable family tragedy that forced him to pull out of the still shooting project. Enter Whedon who had written a Wonder Woman script for the company that never got made. The studio reportedly asked Whedon to do some punch ups on the script to lighten the tone. When Snyder left the film, the studio asked Whedon to step in to the directors seat and finish shooting the film. According to many, Whedon came in and did an almost from page one rewrite while the film’s original writer, Academy Award Winner Chris Terrio called the theatrical cut of the film an act of vandalism and tried, unsuccessfully, to get his name removed from the film.
And this is where the decline of Joss Whedon began. For many people in the industry, it was a well known secret that Whedon was a bully. It seems the first huge public blow came in November 2017 when his ex wife Kai Cole wrote a scathing blog calling Whedon a hypocrite who preached feminist ideals yet called him out on the secret affairs he had over the years. From there, the flood gates seemed to open with many going back through his work and finding problems with the way he sexualized and marginalized his female characters. But the more damning allegations came in 2020 when James Marsters who played vampire Spike on Buffy said that Whedon once pushed him up against a wall and told him he was dead after his character exploded in popularity. A few days later actor Ray Fisher would accuse Whedon of abusive behavior on the set of Justice League including lightening the actors skin tone in post production, something Whedon says he did to the entire film, not just the actors skin.
More and more people would come out and detail the abuse they suffered at the hands of Whedon who at this point seemed more like an ego driven mad producer than the happy go lucky geek god we had come to know. Whedon reportedly forced a stunt double to leave the Buffy series after he told her to stop dating the stunt coordinator while Charisma Carpenter who played Cordelia Chase on Buffy and Angel detailed the cruel abuse she suffered at the hands of Whedon. She said he would constantly degrade her in front of the cast and crew and always threaten to fire her. Carpenters co-stars including Sarah Michelle Gellar, David Boreanaz and Eliza Dushku all publicly supported Carpenter with Gellar even saying that she is forever grateful to be associated with the name Buffy Summers, she didn’t want her name to be forever associated with Joss Whedon. It was Gellar’s comment that gave Buffy star Michelle Trachtenberg the courage to come forward saying that on the set of Buffy, a job she started at just 14 years old, there was a rule that Whedon was not allowed to ever be alone with her. While many kept their silence, the allegations against Whedon kept mounting, until many couldn’t hold their silence any longer. Gal Gadot who played Wonder Woman confirmed a report that Whedon had threatened her career behind the scenes while Ben Affleck has gone on record saying that making Justice League was the worst experience of his professional life.
During the pandemic, HBO let Zach Snyder go back and finish his version of Justice League before Joss came and Joss’d it all up. And it was pretty dang unanimous that Zach’s cut is far superior.
Whedon would try to clear his name in a New York Magazine profile in 2022 titled The Undoing of Joss Whedon that many believe was the final nail in the coffin of Joss Whedon’s career, in it he tries hard to frame his professional career in a way that makes him out to be a passionate hero, but all he does is confirm everything that everyone ever said about him. He doesn’t seem to take accountability for the misery he put so many people through or offer any sort of mea culpa. It all came off a bit self righteous. And it would seem it all did take its toll on his career. Since 2017’s Justice League, Whedon has had only one project in development, the HBO series The Nevers that he actually left before it aired with HBO simply saying they had mutually parted ways. Perhaps his personal life has had more success as in 2021 he married artist Heather Horton. But for now, it seems Whedon is playing the lay low game. Hollywood is a town of forgiveness and the allegations against him aren’t at the Harvey Weinstein level. Is it possible that with time, and a massive dose of humility and hubris, we could see Joss Whedon return to the world of crafting characters that form massive followings? But forgiveness must be earned. Only time will tell…
Dune and Dune: Part Two cast member Rebecca Ferguson says that Part Two is going to be even better than the first
Dune: Part Two, the second half of director Denis Villeneuve’s two-part adaptation of the Frank Herbert novel Dune, which has a release date of November 3, 2023 – and when fans have the chance to see the movie, cast member Rebecca Ferguson says they’ll be seeing a film that’s even better than its predecessor.
Ferguson gave her opinion on Dune: Part Two during an interview on Jake’s Takes, even though she hasn’t actually seen the movie herself yet. Interviewer Jake Hamilton listed Villeneuve’s first Dune as his #1 film of 2021, and asked Ferguson to tell him that the follow-up is awesome. She did just that, saying, “I’m gonna say, Part Two is better than Part One. And that’s me without seeing it, that is me saying it based on what I’ve read, what I’ve seen, what I’ve filmed. I think it’s gonna be better.“
Scripted by Villeneuve, Eric Roth, and Jon Spaihts, Dune: Part One (watch or buy it HERE) stars Timothée Chalamet as Paul Atreides, “a brilliant and gifted young man born into a great destiny beyond his understanding” who must travel to the most dangerous planet in the universe to ensure the future of his family and his people. As malevolent forces explode into conflict over the planet’s exclusive supply of the most precious resource in existence – a commodity capable of unlocking humanity’s greatest potential – only those who can conquer their fear will survive. Coming to us from Warner Bros. and Legendary Entertainment, Dune: Part Two will explore the mythic journey of Paul Atreides as he unites with Chani and the Fremen while on a warpath of revenge against the conspirators who destroyed his family. Facing a choice between the love of his life and the fate of the known universe, he endeavors to prevent a terrible future only he can foresee.
Chalamet and Ferguson are joined in the cast by fellow returning Dune: Part One cast members Zendaya, Javier Bardem, Stellan Skarsgård, Dave Bautista, Charlotte Rampling, Stephen McKinley Henderson, and Josh Brolin, as well as new additions Austin Butler, Tim Blake Nelson, Christopher Walken, Florence Pugh, Souheila Yacoub, and Léa Seydoux.
Villeneuve and Spaihts wrote the screenplay for Dune: Part Two. Villeneuve is also producing the film with Mary Parent, Cale Boyter, Tanya Lapointe, and Patrick McCormick. Spaihts serves as executive producer alongside Josh Grode, Herbert W. Gains, Brian Herbert, Byron Merritt, Kim Herbert, Thomas Tull, Richard P. Rubinstein, and John Harrison. Kevin J. Anderson is creative consultant.
Costume designer Jacqueline West has previously said that Dune: Part Two required a lot more work than its predecessor because “In Part Two, you really dive into the different worlds of Dune. We see what the emperor’s world looks like. We go to his planet. We spend a lot of time on Giedi Prime, the Harkonnen planet. We spend a lot of time in Stellan Skarsgård’s [Vladimir Harkonnen] world. Feyd-Rautha [Harkonnen] also comes into this one, brilliantly played by Austin Butler, Elvis. He is pretty fabulous in it. All the worlds get expanded. It was about creating three separate, different-looking worlds and also revisiting the Bene Gesserits, the age-old ones with these costumes that almost look like Egyptian mummies. I think it’s visually stunning, the sets, the cinematography and the concepts.“
Are you looking forward to Dune: Part Two, and do you believe it could be better than the first movie? Let us know by leaving a comment below.
Scarlett Johansson and Gwynth Paltrow say they’re done with the Marvel Cinematic Universe and discuss Iron Man 2 feud rumors.
Don’t expect Black Widow or Pepper Potts to return to the Marvel Cinematic Universe anytime soon, if ever. According to Scarlett Johansson and Gwyneth Paltrow, their time in the MCU has ended. Speaking with Paltrow on The Goop Podcast, Johansson joined her Marvel co-star to discuss “clean beauty, how she manages to stay off social media, what she’s learned from her marriage,” and, yes, their time spent in the MCU. Johansson and Paltrow collaborated on 2010’s Iron Man 2, with rumors swirling that the duo did not get along. Now, they’re here to set the record straight.
“People ask me, ‘Is it true that you and Scarlett Johansson didn’t get along on ‘Iron Man’?” Paltrow recalls during the interview.
“Is that a rumor?” Johansson responded, sounding genuinely surprised. “You were so nice to me on that movie. I was so petrified. You were so nice to me! You could’ve been awful. I was so out of my comfort zone on that movie. I’d never done anything like that before. Plus, you had established such deep friendships.”
Paltrow told Johansson the Iron Man cast was “so psyched you were there,” adding, “I was so happy to have another woman around.”
When Iron Man 2 was released, the MCU did not feature as many women as it does now. The MCU has grown by leaps and bounds throughout the years. Still, those early days were grim.
“You kept telling me that,” Johansson said. “Then I experienced that later on. When I did ‘Avengers,’ I was one of the few [women]… it was like a big sausage party.”
Paltrow told Johansson she could relate and felt the same when she walked onto the Iron Man set. Paltrow says it felt foreign to see so few women participating in the launch of a cinematic universe. While the MCU was still laying the groundwork for a bright future, some aspects of the start felt off.
“It was fun to be in something that resonated so deeply with people culturally,” Paltrow said. “I had never been in that kind of a blockbuster franchise thing either. It was new for me. But then you went on and did all of those huge films.”
The duo also addressed their MCU futures, and neither appears eager to return for more superhero shenanigans.
“I’m done,” Johansson confirmed. “Chapter is over. I did all that I had to do. Also coming back and playing a character again and again, over a decade of time, is such a unique experience.”
Johansson asked Paltrow if she was done playing Pepper Potts, to which she said, “I think so. I mean, I didn’t die so they can always ask me.”
“I think you may come back at some point,” Johansson quipped.
“Really?” Paltrow said. “A 64-year-old Pepper Potts? How great.”
“100% that’s happening. I can see it. They’re never gonna let you go. Break out that wig, baby,” Johansson half-joked.
Paltrow continued the discussion by saying she thinks she’s too old to climb into the Rescue suit for another film. She also says her Avengers: Endgame cameo was more of a favor than a desire to return to that world.
“It was such a wonderful experience making the first ‘Iron Man’ and then to watch how important it has become to the fans,” Paltrow said fondly.
I’m confident the MCU could find ways to bring Black Widow back (after her emotional death in Avengers: Endgame). Still, let Natasha rest and focus on new characters. As for Pepper, there’s room for her to return, though Paltrow must be convinced to play the part. Again, I think it’s wise for the MCU to move forward and let the legacy of these characters remain in the past. What do you think? Let us know in the comments below.
The Platypod Handle is a vlogger's grip and camera riser, destined to become one of the most diverse creative tools in the company's history. Platypod, the leader in compact tripod alternatives, Platyball and the award-winning eXtreme, is leveraging their broad popularity with their fifth Kickstarter campaign on April 26, 2023.
EAST BRUNSWICK, N.J., April 26, 2023 (Newswire.com)
-
Platypod's fifth Kickstarter campaign launched today on the popular KelbyMedia podcast, "The Grid." The new Platypod Handle joins an extensive product group already established with the Platypod ecosystem. What makes this new accessory unique is its wide versatility in so many different applications.
The Platypod Handle is 1.5" in diameter and extends from 6 ½" to 10 ½" or can be reassembled to 3" in height. At the top stage are eight ¼"-20 threaded sockets to accommodate Platypod elbows and goosenecks. The Handle will support 11 lbs. and has an Arca-compatible base with a stainless steel reinforced 3/8" - 16 socket. It's an all-aluminum machined ergonomic stackable body and is compatible with all Platypods and most common tripods.
"With my inventions, I always try to fill a need with a product that is not currently available. The Platypod Handle combines the functions of a multi-levelriser, video grip and cage, a tripod center column extender, as well as a potential boom arm. Like all our quality products the Handle is finely machined, rock-solidaluminum build and will become indispensable in every artist's imaging tool kit." - Larry Tiefenbrunn, CEO/Inventor, Platypod
The Platypod Kickstarter Campaign runs through May 31, 2023. Although the retail price is set at $69, backers can pledge any one of eight different levels, each with considerable savings for both the handle and other Platypod products. First-day backers will be privy to a super special deal.
There are complete details, images, and videos of the new Platypod Handle on the Kickstarter page where backers can determine the tier they prefer and make a pledge. You can learn more about other Platypod models, accessories, and the company's unique, premium Platyball tripod heads at http://www.platypod.com.
CASTRO VALLEY, Calif., April 26, 2023 (Newswire.com)
-
The RxSight™ Light Adjustable Lens (LAL) is the first and only intraocular lens (IOL) that can be adjusted for improved vision even after cataract surgery. As a longtime premium laser cataract surgeon, Mark Mandel, MD, of Optima Ophthalmic Medical Associates, has always been a pioneer in this field. He is pleased to be at the forefront of this exciting development in IOLs.
For years, premium IOLs have been used in cataract surgery to replace natural lenses that have become clouded with cataracts. These IOLs have a set power that can correct for certain refractive errors like nearsightedness, farsightedness, and astigmatism and allow patients to reduce their dependence on prescription eyewear. Until LALs, however, no premium lens could be adjusted after being inserted into the eye. LALs have light-sensitive molecules that can be manipulated with light. This enables Dr. Mandel to alter the shape and power of the LAL for improved vision.
Following surgery, Dr. Mandel can adjust the LALs multiple times (sometimes only once is necessary) until finding the crispest vision possible for the patient. This allows the patient to stop wearing eyeglasses or contact lenses in most situations (though reading glasses may still be required for small print).
By the age of 80, over half of all Americans have developed cataracts. Although cataracts are one of the leading causes of vision impairment, vision can be restored with a safe and effective cataract surgical procedure. Dr. Mandel is excited to offer even better care to his cataract patients thanks to the advent of LALs, well ahead of fellow ophthalmologists in Northern California.
More About Mark Mandel, MD
Mark Mandel, MD, is a Bay Area premium cataract, LASIK and corneal specialist with offices in San Jose, Hayward, Castro Valley and Concord. He is one of the most experienced cataract surgeons in the state of California. After earning degrees at Oxford University and the UCLA School of Medicine, he completed his ophthalmology residency at California Pacific Medical Center in San Francisco. He is recognized annually as a "TOP DOCTOR" by Castle Connolly and is known among his peers as "the doctor's doctor" because so many of his patients are doctors themselves.
To schedule a consultation for cataract surgery with or without LALs, please contact Dr. Mandel by calling 877-210-2020, extension 3, or by sending an email to [email protected].
Contact Information:
Helen Cole
Refractive Surgery Coordinator [email protected]
A space to give a voice to the Latino community before members of Congress.
WASHINGTON, April 26, 2023 (Newswire.com)
-
The National Hispanic Council on Aging (NHCOA) continues its mission to ensure a dignified life for older adult communities in the United States. As a result, it has set out to be a voice for the community and to advocate for its key challenges in order to achieve substantial, timely and favorable change for all.
To accomplish this, NHCOA will host its virtual Legislative Breakfast on May 2, 2023, at 10:00 a.m. (EST) via GoToWebinar. The event seeks to open the discussion on key issues affecting Latinos before members of Congress, who will be the special guests of this new project. NHCOA also aims to bring together legislators and constituents to discuss legislative priorities and understanding from leaders of the older adult communities in the U.S. This event aims to facilitate discussions around the preeminent matters impacting older adults today, such as improving the access and affordability of drugs to treat obesity and Alzheimer's disease, as well as the importance of vaccination schedules that include immunizations against influenza, pneumococcus and shingles.
This space will also serve to address other issues related to health care for older adults, such as barriers to access to prescription drugs, health insurance barriers, and the importance of Medicare for communities. There will also be discussions regarding access to treatment for chronic diseases such as obesity and Alzheimer's and the challenges in caring for patients with these conditions and health disparities between black and Latino communities, exacerbated by the inequities uncovered by the pandemic.
The Legislative Breakfast will feature presentations by NHCOA experts along with national and international organizations working with older adults, among others. The event is free and open to the public.
For questions, contact Christine Perez at [email protected] or 202-347-9733.
About NHCOA: NHCOA is the leading national organization working to improve the lives of Hispanic older adults, their families, and their caregivers. Headquartered in Washington, D.C., NHCOA has been a strong voice dedicated to promoting, educating, and advocating for research, policy, and practice in the areas of economic security, health, and housing for Hispanic older adults, families, and caregivers for the last 51 years.
For more information about NHCOA, call 202-347-9733 or visit www.NHCOA.org.
Online ADHD testing and assessment leader provides guidance for people managing symptoms of the disorders.
GRAND RAPIDS, Mich., April 26, 2023 (Newswire.com)
-
ADHD Online, the leader in online ADHD assessment and diagnosis, reports that recent studies show that those with body dysmorphic disorder (BDD) are more likely to have ADHD than those without BDD, and that people with ADHD are more likely to have BDD.
BDD is a condition typified by a preoccupation with imagined or slight defects in one's appearance, causing distress or impairing the person's ability to manage everyday activities.
A 2018 study conducted by researchers from the Karolinska Institutet in Sweden found that patients with BDD were twice as likely to be diagnosed with ADHD, and a 2019 study revealed that body dysmorphia is more prevalent with conditions of obsessive compulsive disorder, anxiety and ADHD.
"Living with body dysmorphic disorder can be overwhelming at times, and it can be even more of a challenge for people with ADHD," said ADHD Online CEO Zachariah Booker. "BDD can make people focus on perceived flaws and on correcting them as a way to regain a sense of control. ADHD can amplify those tendencies because people with the condition are already more prone to impulsivity and distraction and have trouble with organization. That makes it far easier to follow the urge to brush your hair or pick at your skin instead of doing chores or managing uncomfortable emotions."
Booker added that people with ADHD often have low self-esteem, which is caused by a lack of proper support and constant criticism that can leave people feeling inadequate.
ADHD Online suggests several ways people with ADHD can manage BDD:
Improve their self-esteem. They should avoid the practice of comparing themselves to others, so they don't hold unrealistic anchors of ideal beauty. Instead, they should focus on their unique qualities and strengths.
Practice self-compassion. They should challenge the negative assumptions of their internal critic, possibly through meditation and positive affirmations, with the goal of being accepting, understanding and empathetic toward themselves.
Learn to shift focus. With practice, they can learn to shift their focus from their body and negative thoughts by practicing mindfulness. One way is to refocus on their surroundings or current task, like making dinner or walking a dog.
Increase body awareness. Practices like yoga, tai chi or body scan meditation help them focus on their body and its sensations and may resolve problems arising from ignoring what the body is saying or fighting against it.
Connect with others. They can reach out to friends and family, or nonprofit organizations or local or online groups that offer peer support. Making connections with people who respect them as they are, and understand ADHD and BDD, will provide valuable reinforcement.
Self-care. Proper sleep, diet and exercise can improve mood, lower anxiety and help manage ADHD symptoms. Regular physical activity can also help raise their self-esteem and feelings of body positivity. It's best to avoid alcohol and recreational drugs, which can disrupt physical and mental health.
To learn more about ADHD Online, visit https://adhdonline.com/, and to read more about the link between BDD and ADHD visit the link here.
About ADHD Online
ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with results from licensed psychologists. ADHD Online is active in all 50 states.